The conference call will be held at 4:30 p.m. ET, after the market closes.
-- Conference Call and Webcast to Follow -- |
| [07-November-2017] |
| SAN FRANCISCO, Nov. 7, 2017 /PRNewswire/ -- Audentes Therapeutics (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, will host a conference call to report its third quarter 2017 financial results and provide a corporate update on Tuesday, November 14, 2017. The conference call will be held at 4:30 p.m. ET, after the market closes. To access a live webcast of the conference call, please visit the Investor and Media page of the Audentes website at www.audentestx.com. Alternatively, please call 1-833-659-8620 (U.S.) or 1-409-767-9247 (international) and dial the conference ID 2599735 to access the call. A replay of the webcast will be available on the Audentes website for approximately 30 days. About Audentes Therapeutics, Inc. For more information regarding Audentes, please visit www.audentestx.com. Audentes Contacts: Investor Contact: Media Contact:
View original content with multimedia:http://www.prnewswire.com/news-releases/audentes-therapeutics-to-release-third-quarter-2017-financial-results-and-provide-corporate-update-on-tuesday-november-14-2017-300550735.html SOURCE Audentes Therapeutics, Inc. | ||
Company Codes: NASDAQ-NMS:BOLD |
